Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-614 in dry eye disease
NCT05411367Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of cinhyaluronate sodium in dry eye disease (DED), sponsored by Seikagaku Corporation. Started Jul 2022; status: completed.
02
Drugs
cinhyaluronate sodium
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05411367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05411367.